Your browser doesn't support javascript.
loading
Momordica cochinchinensis (Gac) Seed Extracts Induce Apoptosis and Necrosis in Melanoma Cells.
Nguyen, Dao; Holien, Jessica; Dekiwadia, Chaitali; Thrimawithana, Thilini; Piva, Terrence; Huynh, Tien.
Afiliação
  • Nguyen D; School of Science, RMIT University, P.O. Box 71, Bundoora 3083, Australia.
  • Holien J; Faculty of Agriculture and Forestry, Tay Nguyen University, 567 Le Duan Street, Buon Ma Thuot City 63000, Vietnam.
  • Dekiwadia C; School of Science, RMIT University, P.O. Box 71, Bundoora 3083, Australia.
  • Thrimawithana T; RMIT Microscopy and Microanalysis Facility, GPO 2476, Melbourne 3001, Australia.
  • Piva T; School of Health and Biomedical Sciences, RMIT University, P.O. Box 71, Bundoora 3083, Australia.
  • Huynh T; School of Health and Biomedical Sciences, RMIT University, P.O. Box 71, Bundoora 3083, Australia.
Pharmaceuticals (Basel) ; 16(1)2023 Jan 09.
Article em En | MEDLINE | ID: mdl-36678596
Momordica cochinchinensis is a herbal medicine used throughout Asia and this study investigated the antimelanoma potentials and molecular mechanisms of M. cochinchinensis seed with emphasis on extraction to optimise bioactivity. Overall, the aqueous extract was superior, with a wider diversity and higher concentration of proteins and peptides that was more cytotoxic to the melanoma cells than other extraction solvents. The IC50 of the aqueous extract on melanoma cells were similar to treatment with current anticancer drugs, vemurafenib and cisplatin. This cytotoxicity was cancer-specific with lower cytotoxic effects on HaCaT epidermal keratinocytes. Cytotoxicity correlated with MAPK signalling pathways leading to apoptosis and necrosis induced by triggering tumour necrosis factor receptor-1 (TNFR1), reducing the expression of nuclear factor kappa B (NF-kB), and suppression of BRAF/MEK. This efficacy of M. cochinchinensis seed extracts on melanoma cells provides a platform for future clinical trials as potent adjunctive therapy for metastatic melanoma.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália